Silvercrest Asset Management
ITCI icon

Silvercrest Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Silvercrest Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-118,265
Closed -$9.88M – 885
2024
Q4 		$9.88M Sell
118,265
-583
-0.5% -$47.9K 0.07% 302
2024
Q3 		$8.7M Sell
118,848
-722
-0.6% -$54.3K 0.06% 284
2024
Q2 		$8.19M Buy
119,570
+77,294
+183% +$5.36M 0.06% 300
2024
Q1 		$2.93M Sell
42,276
-13,507
-24% -$928K 0.02% 460
2023
Q4 		$4M Sell
55,783
-22,591
-29% -$1.3M 0.03% 412
2023
Q3 		$4.08M Sell
78,374
-70
-0.1% -$4.08K 0.03% 394
2023
Q2 		$4.97M Buy
78,444
+11,726
+18% +$731K 0.04% 369
2023
Q1 		$3.61M Sell
66,718
-31,756
-32% -$1.54M 0.03% 403
2022
Q4 		$5.21M Sell
98,474
-1,456
-1% -$73K 0.04% 339
2022
Q3 		$4.65M Sell
99,930
-2,484
-2% -$130K 0.04% 341
2022
Q2 		$5.85M Sell
102,414
-5,424
-5% -$308K 0.04% 302
2022
Q1 		$6.6M Buy
107,838
+1,279
+1% +$66.4K 0.04% 327
2021
Q4 		$5.58M Sell
106,559
-60,752
-36% -$2.55M 0.04% 356
2021
Q3 		$6.24M Sell
167,311
-2,683
-2% -$93.3K 0.04% 352
2021
Q2 		$6.94M Sell
169,994
-339
-0.2% -$12.5K 0.05% 335
2021
Q1 		$5.78M Sell
170,333
-21,517
-11% -$746K 0.04% 356
2020
Q4 		$6.1M Buy
+191,850
New +$5.04M 0.04% 337

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
HBK Investments
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Davidson Kempner Capital Management
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
UBS O'Connor
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Silvercrest Asset Management's ITCI Position: Q1 2025 in Review

Silvercrest Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2025, closing a stake of 118,265 shares — an estimated $9.88M sold.

Silvercrest Asset Management first reported a position in ITCI in Q4 2020 and held it in 17 quarters. The position peaked at $9.88M in Q4 2024. 395 funds tracked by Wall St. Rank hold ITCI as of Q1 2025.

  • Silvercrest Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 118,265 Intra-Cellular Therapies Inc. shares in Q1 2025, an estimated $9.88M.
  • Silvercrest Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q4 2020 and held it in 17 quarters.
  • Silvercrest Asset Management's Intra-Cellular Therapies Inc. position peaked at $9.88M in Q4 2024.
  • 395 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2025.

Based on Silvercrest Asset Management's 13F filing for Q1 2025, filed 15 May 2025.